Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ZESTORETIC | 25MG 20MG | TABLET | Resolved | 2019-12-18 | 2020-01-18 | 101520 |
ZESTORETIC | 25MG 20MG | TABLET | Actual shortage | 2023-11-28 | 2023-12-16 | 211675 |
ZESTORETIC | 12.5MG 10MG | TABLET | Resolved | 2023-06-19 | 2023-07-13 | 195535 |
ZESTORETIC | 10MG 12.5MG | TABLET | Actual shortage | 2023-08-24 | 2023-12-05 | 202917 |
ZESTORETIC | 10MG 12.5MG | TABLET | Resolved | 2023-09-15 | 2023-09-20 | 204548 |
ZESTORETIC | 12.5MG 20MG | TABLET | Resolved | 2023-08-02 | 2023-08-03 | 200688 |
ZESTORETIC | 12.5MG 20MG | TABLET | Resolved | 2023-11-28 | 2024-01-23 | 211672 |
VISKAZIDE | 25MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151232 |
VISKAZIDE | 50MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151235 |
VASERETIC | 25MG 8MG | TABLET | Resolved | 2017-05-23 | 2017-06-07 | 10855 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |